- Home
- ZBIO vs AMTM Comparison
ZBIO vs AMTM Comparison
Compare ZBIO & AMTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- AMTM
- Stock Information
- Founded
- ZBIO 2019
- AMTM 2020
- Country
- ZBIO United States
- AMTM United States
- Employees
- ZBIO N/A
- AMTM N/A
- Industry
- ZBIO
- AMTM
- Sector
- ZBIO
- AMTM
- Exchange
- ZBIO NYSE
- AMTM NYSE
- Market Cap
- ZBIO 389.2M
- AMTM 5.6B
- IPO Year
- ZBIO 2024
- AMTM N/A
- Fundamental
- Price
- ZBIO $11.18
- AMTM $23.65
- Analyst Decision
- ZBIO Strong Buy
- AMTM Buy
- Analyst Count
- ZBIO 7
- AMTM 6
- Target Price
- ZBIO $32.29
- AMTM $25.50
- AVG Volume (30 Days)
- ZBIO 175.9K
- AMTM 1.8M
- Earning Date
- ZBIO 08-16-2025
- AMTM 08-05-2025
- Dividend Yield
- ZBIO N/A
- AMTM N/A
- EPS Growth
- ZBIO N/A
- AMTM N/A
- EPS
- ZBIO N/A
- AMTM 0.10
- Revenue
- ZBIO $15,000,000.00
- AMTM $11,261,000,000.00
- Revenue This Year
- ZBIO $206.00
- AMTM $70.66
- Revenue Next Year
- ZBIO $41.92
- AMTM $2.26
- P/E Ratio
- ZBIO N/A
- AMTM $248.06
- Revenue Growth
- ZBIO N/A
- AMTM 38.56
- 52 Week Low
- ZBIO $5.83
- AMTM $16.01
- 52 Week High
- ZBIO $26.25
- AMTM $34.50
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- AMTM N/A
- Support Level
- ZBIO N/A
- AMTM N/A
- Resistance Level
- ZBIO N/A
- AMTM N/A
- Average True Range (ATR)
- ZBIO 0.00
- AMTM 0.00
- MACD
- ZBIO 0.00
- AMTM 0.00
- Stochastic Oscillator
- ZBIO 0.00
- AMTM 0.00
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About AMTM AMENTUM HOLDINGS INC
Amentum Holdings Inc is engaged in engineering and technology solutions. The United States and its allies trust it to address their technical and complex scientific, security, and sustainability challenges.